Phibro Animal Health Corporation Total Assets

Latest as of June 2026: $1.50 Billion USD

Phibro Animal Health Corporation total assets. Based on the latest financial reports, Phibro Animal Health Corporation (PAHC) holds total assets worth $1.50 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Phibro Animal Health Corporation cash flow conversion for how efficiently the company converts equity into cash flow.

Total Assets of Phibro Animal Health Corporation (2000–2026)

Total assets of Phibro Animal Health Corporation from 2000 to 2026. This chart illustrates how Phibro Animal Health Corporation's total assets have evolved over time, based on quarterly financial data. See Phibro Animal Health Corporation stock price for real-time trading data and today's change.

Phibro Animal Health Corporation - Asset Composition Analysis

Phibro Animal Health Corporation Total Assets Breakdown (June 2026)

Phibro Animal Health Corporation total assets breakdown as of June 2026. Phibro Animal Health Corporation's total assets of $1.50 Billion consist of 62.3% current assets and 37.7% non-current assets. Explore Phibro Animal Health Corporation (PAHC) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 4.1%
Accounts Receivable $238.79 Million 15.9%
Inventory $534.88 Million 35.6%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $30.05 Million 2.0%
Goodwill $60.05 Million 4.0%

Asset Composition Trend (2000–2026)

This chart illustrates how Phibro Animal Health Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Phibro Animal Health Corporation's current assets represent 62.3% of total assets in 2026, an increase from 58.0% in 2000.
  • Cash Position: Cash and equivalents constituted 4.1% of total assets in 2026, up from 0.9% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 2.0% in 2000.
  • Asset Diversification: The largest asset category is inventory at 35.6% of total assets.

Phibro Animal Health Corporation Competitors by Total Assets

Key competitors of Phibro Animal Health Corporation based on total assets are shown below.

Company Country Total Assets
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
China CN¥68.33 Billion
Ahn-Gook Pharmaceutical Co. Ltd
KQ:001540
Korea ₩303.42 Billion
Viatris Inc
NASDAQ:VTRS
USA $35.04 Billion
Emcure Pharmaceuticals Ltd
NSE:EMCURE
India Rs96.12 Billion
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
China CN¥13.81 Billion
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
China CN¥9.94 Billion
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SHG:688505
China CN¥2.39 Billion
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829
China CN¥7.35 Billion

Phibro Animal Health Corporation - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.96 2.76 3.27
Quick Ratio 1.27 1.25 1.82
Cash Ratio 0.00 0.00 0.00
Working Capital $619.04 Million $517.13 Million $346.04 Million

Phibro Animal Health Corporation - Advanced Valuation Insights

This section examines the relationship between Phibro Animal Health Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 3.86
Latest Market Cap to Assets Ratio 0.54
Asset Growth Rate (YoY) 10.3%
Total Assets $1.50 Billion
Market Capitalization $810.03 Million USD

Valuation Analysis

Below Book Valuation: The market values Phibro Animal Health Corporation's assets below their book value (0.54x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Phibro Animal Health Corporation's assets grew by 10.3% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Phibro Animal Health Corporation (2000–2026)

The table below shows the annual total assets of Phibro Animal Health Corporation from 2000 to 2026.

Year Total Assets Change
2026-06-30 $1.50 Billion +10.31%
2025-06-30 $1.36 Billion +38.56%
2024-06-30 $982.18 Million +1.11%
2023-06-30 $971.40 Million +4.26%
2022-06-30 $931.70 Million +10.74%
2021-06-30 $841.33 Million +7.30%
2020-06-30 $784.10 Million +7.90%
2019-06-30 $726.67 Million +8.19%
2018-06-30 $671.68 Million +7.74%
2017-06-30 $623.40 Million +2.13%
2016-06-30 $610.37 Million +23.73%
2015-06-30 $493.32 Million +4.45%
2014-06-30 $472.32 Million -0.38%
2013-06-30 $474.14 Million +7.54%
2012-06-30 $440.91 Million +21.92%
2009-06-30 $361.63 Million +11.24%
2008-06-30 $325.07 Million +19.56%
2007-06-30 $271.90 Million +9.50%
2006-06-30 $248.30 Million -1.90%
2005-06-30 $253.10 Million +4.85%
2004-06-30 $241.40 Million -11.99%
2003-06-30 $274.30 Million -7.46%
2002-06-30 $296.40 Million -10.18%
2001-06-30 $330.00 Million +27.66%
2000-06-30 $258.50 Million --

About Phibro Animal Health Corporation

NASDAQ:PAHC USA Drug Manufacturers - Specialty & Generic
Market Cap
$810.03 Million
Market Cap Rank
#9581 Global
#2665 in USA
Share Price
$38.38
Change (1 day)
-1.67%
52-Week Range
$28.52 - $59.58
All Time High
$59.58
About

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including po… Read more